We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
-4.71%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$109B
AUM Growth
+$10.3B
Cap. Flow
+$17.5B
Cap. Flow %
16%
Top 10 Hldgs %
37.15%
Holding
12,038
New
1,603
Increased
4,441
Reduced
4,088
Closed
1,637

Sector Composition

Rank Sector Weight
1 Technology 0.67%
2 Consumer Discretionary 0.37%
3 Industrials 0.24%
4 Healthcare 0.22%
5 Financials 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAN
9351
DELISTED
eMagin Corporation
EMAN
$6K ﹤0.01%
5,373
-14,677
-73% -$18.4K
ABST
9352
CALL
DELISTED
Absolute Software Corp
ABST
$6K ﹤0.01%
800
+500
+167% +$4.24K
BGRY
9353
PUT
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$6K ﹤0.01%
2,100
-5,200
-71% -$18.5K
NYMX
9354
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$6K ﹤0.01%
5,400
-400
-7% -$618
NYMX
9355
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
$6K ﹤0.01%
5,300
+2,300
+77% +$3.55K
SQZ
9356
DELISTED
SQZ Biotechnologies Company
SQZ
$6K ﹤0.01%
1,424
+1,324
+1,324% +$8.41K
ACOR
9357
PUT
DELISTED
Acorda Therapeutics
ACOR
$6K ﹤0.01%
200
-285
-59% -$11.2K
TCRR
9358
CALL
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$6K ﹤0.01%
2,300
-700
-23% -$2.2K
TCRR
9359
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$6K ﹤0.01%
2,280
+1,773
+350% +$5.58K
ALR
9360
PUT
DELISTED
AlerisLife Inc
ALR
$6K ﹤0.01%
+3,000
New +$8.04K
FSTX
9361
PUT
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6K ﹤0.01%
1,700
-1,200
-41% -$4.43K
ATNX
9362
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
$6K ﹤0.01%
385
+195
+103% +$3.82K
LFG
9363
CALL
DELISTED
Archaea Energy Inc.
LFG
$6K ﹤0.01%
300
-5,500
-95% -$100K
LGV
9364
DELISTED
Longview Acquisition Corp. II
LGV
$6K ﹤0.01%
+699
New +$6.81K
ECOM
9365
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$6K ﹤0.01%
400
-2,600
-87% -$49.3K
STON
9366
PUT
DELISTED
StoneMor Inc.
STON
$6K ﹤0.01%
2,400
+1,500
+167% +$3.86K
NPTN
9367
PUT
DELISTED
NEOPHOTONICS CORP
NPTN
$6K ﹤0.01%
400
-1,300
-76% -$19.8K
TVTY
9368
CALL
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$6K ﹤0.01%
+200
New +$5.41K
DZSI
9369
DELISTED
DZS Inc. Common Stock
DZSI
$6K ﹤0.01%
453
-471
-51% -$6.82K
AEMD icon
9370
Aethlon Medical
AEMD
$1.57M
$5K ﹤0.01%
5
-16
-76% -$19.1K
ANIK icon
9371
CALL
Anika Therapeutics
ANIK
$200M
$5K ﹤0.01%
+200
New +$6.1K
ANIX icon
9372
PUT
Anixa Biosciences
ANIX
$116M
$5K ﹤0.01%
2,100
+100
+5% +$293
APOG icon
9373
Apogee Enterprises
APOG
$861M
$5K ﹤0.01%
+116
New +$5.4K
ARKF icon
9374
ARK Blockchain & Fintech Innovation ETF
ARKF
$740M
$5K ﹤0.01%
+200
New +$6.15K
ASH icon
9375
Ashland
ASH
$3.04B
$5K ﹤0.01%
57
-80
-58% -$7.69K

Similar funds

Simplex Trading's Q1 2022 Portfolio in Review

As of Q1 2022, Simplex Trading held 12,038 positions worth $109B, up 10% from $99B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Simplex Trading deployed $17.5B of net new capital in Q1 2022, opening 1,603 new positions and adding to 4,441 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 652,921 shares worth $86.2M.

By sector, the portfolio is most concentrated in Technology at 0.67% of assets, up from 0.61% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Verizon, an estimated $42.5M trimmed.

  • Simplex Trading's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 652,921 shares worth $86.2M.
  • Simplex Trading added most to Apple in Q1 2022, an estimated $179M increase.
  • Simplex Trading's biggest Q1 2022 reduction was Verizon, cutting an estimated $42.5M.
  • Simplex Trading fully exited State Street Financial Select Sector SPDR ETF in Q1 2022, selling an estimated $42.8M.
  • Simplex Trading's ten largest holdings make up 37% of its $109B portfolio in Q1 2022.
  • Simplex Trading opened 1,603 new positions and closed 1,637 in Q1 2022.
  • Simplex Trading's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.